Inhibition by indomethacin of spontaneous mammary tumorigenesis in SHN mice.
This experiment was designed to examine the effects of indomethacin, a potent prostaglandin synthesis inhibitor, on spontaneous mammary tumors in mice. The growth of established mammary tumors and the appearance of new tumors in multiparous SHN mice were significantly suppressed by the subcutaneous implantation of pellets of indomethacin diluted to 1/12 with cholesterol. Furthermore, the same treatment inhibited normal and preneoplastic mammary gland growth in virgin SHN mice. The pattern of estrous cycles, ovarian structure, and plasma prolactin levels were not affected significantly by the treatment. All results have demonstrated that indomethacin inhibits mammary tumorigenesis of mice primarily by route(s) other than the endocrine system under the present experimental conditions. Indomethacin would be the first agent that appears to inhibit the growth of spontaneous mammary tumors of palpable size in mice.
D000818:Animals; D001835:Body Weight; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D004971:Estrus; D005260:Female; D007213:Indomethacin / Q000494:pharmacology*; D008325:Mammary Neoplasms, Experimental / Q000517:prevention & control*; D051379:Mice; D011230:Precancerous Conditions / Q000473:pathology; D011388:Prolactin / Q000097:blood
D011388:Prolactin; D007213:Indomethacin